Dr. Bob Clarke, CEO of Pulmatrix, Gets Market Exclusivity Approval from FDA on Their New Developing Product

Dr. Bob Clarke, CEO of Pulmatrix, Gets Market Exclusivity Approval from FDA on Their New Developing Product

Everett Jolly Interviews Dr. Bob Clarke, CEO for Pulmatrix, Inc. (PULM), and they talk about how they were awarded market exclusivity from the FDA for their developing product.

PULM

 

– Visit https://upticknewswire.com for more interviews and the latest penny stock news –

 

We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.

Leave a Reply

Close Menu